The Effect of Percutaneous Kirschner Wire Technique in Management of CPT Under One Year Old

October 20, 2020 updated by: Hunan Children's Hospital

The Effect of Percutaneous Kirschner Wire Technique in Management of Congenital Pseudarthrosis of Tibia Under One Year Old

The aim of this study was to investigate the effect of percutaneous kirschner wire in management of Congenital Pseudarthrosis of Tibia in children younger than 1 year of age. This study was to determine the union rates of congenital pseudarthrosis in children operated before 1 year of age to identify growth abnormalities in the affected limb ,including ankle valgus,tibia valgus,and shortening.

Study Overview

Status

Unknown

Intervention / Treatment

Detailed Description

Currently, the timing of surgery for congenital pseudarthrosis of the tibia is a controversial issue. The investigators use percutaneous kirschner wire technique to manage the Congenital Pseudarthrosis of Tibia in children younger than 1 year of age.To investigate the effect of percutaneous kirschner wire in management of Congenital Pseudarthrosis of Tibia in children younger than 1 year of age. Bone uion rate,average time of healing, ankle valgus, limb length discrepancy, tibia axis alignment are recorded and evaluated.

Study Type

Interventional

Enrollment (Anticipated)

100

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

  • Name: Kun Liu, MD
  • Phone Number: 008615084796158
  • Email: lk998@sina.com

Study Contact Backup

Study Locations

    • Hunan
      • Changsha, Hunan, China, 417000
        • Recruiting
        • Kun Liu
        • Contact:

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

1 month to 1 year (Child)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Description

Inclusion Criteria:

  • All patients did not undergo procedures
  • Patients with Crawford type IV CPT treated with Percutaneous Kirschner wire techniques
  • The age during surgery was less than 12 months old

Exclusion Criteria:

  • Patients with pseudarthrosis of tibia caused by trauma,infection, etc

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: N/A
  • Interventional Model: Single Group Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: surgery
Percutaneous Kirschner wire
retrograde percutaneous kirschner wire was applied to stabilize the tibia.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Primary union score (range,4-12 score)
Time Frame: 9 months post-operation
X ray score from tibia pseudarthrosis in anterior and posterior (AP )and lateral X ray. ("RUST" score:radiographic union scoring system for tibial fracture healing)
9 months post-operation

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Refracture(Cortical discontinuity)
Time Frame: 0.5 , 1,2,3,4,5,6,7,8,9,10 years after the fracture is healed
Refracture was defined as an obvious fracture(Cortical discontinuity) on a plain radiograph,following the union at the site of the tibia.
0.5 , 1,2,3,4,5,6,7,8,9,10 years after the fracture is healed
Residual Deformity-proximal tibia angulation(range,0°-90°)
Time Frame: pre-operation and 0.5 , 1,2,3,4,5,6,7,8,9,10 years post-operation ]
measurement of the angulation of proximal tibia in anterior and posterior (AP )and lateral X ray.Proximal tibial valgus is created by the intersection of a line parallel to the proximal physis and another line along the axis of the proximal third of diaphysis in the tibia.
pre-operation and 0.5 , 1,2,3,4,5,6,7,8,9,10 years post-operation ]
Residual Deformity-Limb length discrepancy
Time Frame: pre-operation and 0.5 , 1,2,3,4,5,6,7,8,9,10 years post-operation
measurement of the length difference of both tibia in AP and lateral X ray.Picture Archiving and Communication System (PACS) is used to measure the length of the tibia (The investigators measure the distance between the midpoint of the proximal tibial epiphyseal plate and the midpoint of distal tibia epiphyseal plate).
pre-operation and 0.5 , 1,2,3,4,5,6,7,8,9,10 years post-operation
Residual Deformity-ankle valgus angulation(range,0°-90°)
Time Frame: pre-operation and 0.5 , 1,2,3,4,5,6,7,8,9,10 years post-operation
measurement of the angulation between the distal tibia and ankle joint.Ankle valgus is assessed by the tibiotalar angle measured at the intersection of the mid-diaphyseal line of the tibia and a line drawn across the flat subchondral line of the talar dome.
pre-operation and 0.5 , 1,2,3,4,5,6,7,8,9,10 years post-operation

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

August 1, 2015

Primary Completion (Anticipated)

December 1, 2022

Study Completion (Anticipated)

December 1, 2022

Study Registration Dates

First Submitted

August 15, 2017

First Submitted That Met QC Criteria

August 19, 2017

First Posted (Actual)

August 22, 2017

Study Record Updates

Last Update Posted (Actual)

October 22, 2020

Last Update Submitted That Met QC Criteria

October 20, 2020

Last Verified

October 1, 2020

More Information

Terms related to this study

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Congenital Pseudarthrosis of Tibia

Clinical Trials on kirschner wire

3
Subscribe